Pfizer's Diversified Drug Portfolio Fuels Growth as COVID Sales Decline
Pfizer Inc. (NYSE: PFE ) stock rose Tuesday after the drugmaker reported better-than-expected second-quarter results and raised its fiscal 2026 revenue outlook while affirming its earnings guidance. Pfizer Beats Estimates, Lifts Revenue Outlook Chairman and CEO Albert Bourla said the company’s launched and acquired pro